A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)

NCT00902369 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: AK106-001616
DRUG: Placebo
DRUG: Active comparator

Sponsor

Asahi Kasei Therapeutics Corporation